glp-1 zepbound FDA approval for (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and hormone receptors - Eli Lilly Zepbound How It Works: Dual

Primary care physicians often make decisions regarding the initiation of basal insulin in T2D, as they work closely with patients and are well placed to discuss and manage the transition to basal insulin therapy

Purpose of Review The development of long-acting incretin receptor agonists represents a significant advance in the fight against the concurrent epidemics of type 2 diabetes mellitus (T2DM) and obesity

Additionally, it has shown improvements in blood pressure, lipid profiles, and blood sugar

As new uses emerge, companies must carefully monitor patient health and integrate behavior change strategies

Source in comments.

GLP-1 injections are a medication used for weight loss, to treat type 2 diabetes and to reduce the risk of major adverse cardiovascular events